Identification of novel targetable mutations in metastatic anorectal melanoma by next-generation sequencing.
作者信息
Cai Emily D, Kim Jinah
机构信息
Department of Pathology, Stanford University School of Medicine, Stanford, California.
Department of Dermatology, Stanford University Medical Center, Stanford, California.
出版信息
JAAD Case Rep. 2017 Nov 6;3(6):539-541. doi: 10.1016/j.jdcr.2017.09.036. eCollection 2017 Nov.
Abstract
摘要
相似文献
1
Identification of novel targetable mutations in metastatic anorectal melanoma by next-generation sequencing.通过二代测序鉴定转移性肛管直肠癌中的新型可靶向突变
JAAD Case Rep. 2017 Nov 6;3(6):539-541. doi: 10.1016/j.jdcr.2017.09.036. eCollection 2017 Nov.
2
Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma.对117份常规临床样本进行靶向二代测序，进一步深入了解葡萄膜黑色素瘤的分子格局。
Cancers (Basel). 2020 Apr 23;12(4):1039. doi: 10.3390/cancers12041039.
3
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.采用下一代测序技术对软组织肉瘤进行分子谱分析：迈向精准治疗的初步研究。
Hum Pathol. 2014 Aug;45(8):1563-71. doi: 10.1016/j.humpath.2014.04.012. Epub 2014 Apr 24.
4
Comparison of targeted next generation sequencing (NGS) versus isolated BRAF V600E analysis in patients with metastatic melanoma.对比转移性黑色素瘤患者的靶向下一代测序（NGS）与 BRAF V600E 单独分析。
Virchows Arch. 2018 Sep;473(3):371-377. doi: 10.1007/s00428-018-2393-2. Epub 2018 Jun 21.
5
Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors.当染色体微阵列与下一代测序平台联合用于分析肺癌和结直肠癌肿瘤时，可增强可靶向基因畸变的检测。
Cancer Genet. 2016 Apr;209(4):119-29. doi: 10.1016/j.cancergen.2015.12.011. Epub 2016 Jan 6.
6
Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.使用下一代测序（NGS）平台从存档肿瘤标本中诊断致病性种系 BRCA1/2 突变。
Gynecol Oncol. 2019 Nov;155(2):275-279. doi: 10.1016/j.ygyno.2019.08.027. Epub 2019 Aug 31.
7
Panel sequencing melanomas.面板测序黑色素瘤。
J Invest Dermatol. 2015 Feb;135(2):335-336. doi: 10.1038/jid.2014.420.
8
Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.靶向新一代测序用于可靠检测肺腺癌中可靶向重排——一项单中心回顾性研究
Pathol Res Pract. 2018 Apr;214(4):572-578. doi: 10.1016/j.prp.2018.02.001. Epub 2018 Feb 16.
9
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.黏膜黑色素瘤的靶向二代测序鉴定出常见的NF1和RAS突变。
Oncotarget. 2017 Jun 20;8(25):40683-40692. doi: 10.18632/oncotarget.16542.
10
Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.在常规实验室实践中实施下一代测序技术进行体细胞突变检测。
Pathology. 2018 Jun;50(4):389-401. doi: 10.1016/j.pathol.2018.01.005. Epub 2018 May 8.
引用本文的文献
1
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.用于大疱性表皮松解症的可扩展和 cGMP 兼容的自体器官型细胞疗法。
Nat Commun. 2024 Jul 11;15(1):5834. doi: 10.1038/s41467-024-49400-z.
2
The dual role of Nrf2 in melanoma: a systematic review.Nrf2 在黑色素瘤中的双重作用：系统评价。
BMC Mol Cell Biol. 2023 Feb 6;24(1):5. doi: 10.1186/s12860-023-00466-5.
3
Efficacy and prognosis of surgical treatment in ARMM and its effects on immune and inflammatory profiles.ARMM手术治疗的疗效与预后及其对免疫和炎症特征的影响。
Exp Ther Med. 2020 Dec;20(6):277. doi: 10.3892/etm.2020.9407. Epub 2020 Oct 27.
本文引用的文献
1
Targeted agents and immunotherapies: optimizing outcomes in melanoma.靶向药物和免疫疗法：优化黑色素瘤的治疗效果。
Nat Rev Clin Oncol. 2017 Aug;14(8):463-482. doi: 10.1038/nrclinonc.2017.43. Epub 2017 Apr 4.
2
Identification of recurrent mutational events in anorectal melanoma.肛管黑色素瘤中复发性突变事件的鉴定
Mod Pathol. 2017 Feb;30(2):286-296. doi: 10.1038/modpathol.2016.179. Epub 2016 Oct 14.
3
An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.NFE2L2、KEAP1、8-羟基-2'-脱氧鸟苷以及上皮-间质转化标志物SNAI2、ZEB1和TWIST1在转移性黑色素瘤中的免疫组织化学研究
Histol Histopathol. 2017 Feb;32(2):129-136. doi: 10.14670/HH-11-778. Epub 2016 May 12.
4
The Genetic Evolution of Melanoma from Precursor Lesions.黑色素瘤从前期病变的遗传进化。
N Engl J Med. 2015 Nov 12;373(20):1926-36. doi: 10.1056/NEJMoa1502583.
5
Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.PTEN蛋白表达完全缺失与BRAFV600突变的IIIB/C期黑色素瘤患者发生脑转移的时间缩短及生存期相关。
Clin Cancer Res. 2014 Nov 1;20(21):5527-36. doi: 10.1158/1078-0432.CCR-14-1027. Epub 2014 Aug 27.
6
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.乳腺癌和皮肤黑色素瘤患者中的BRCA1、BRCA2、TP53和CDKN2A种系突变。
Fam Cancer. 2007;6(4):453-61. doi: 10.1007/s10689-007-9143-y. Epub 2007 Jul 12.
7
c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.c-Met自分泌激活诱导恶性黑色素瘤的发展及转移表型的获得。
Cancer Res. 1998 Nov 15;58(22):5157-67.
Zotero 插件